| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |